Key Takeaway: NASA’s 2026 NIAC selections demonstrate how early-stage, federally supported research can lay the foundation for future aerospace breakthroughs. As these technologies mature, innovators should consider intellectual property strategies,…
Key Takeaway: California court holds that drug manufacturers do not have a duty to commercialize a safer drug to replace a nondefective one. In the Gilead Tenofovir Cases, a group…
Key Takeaways: Sophia Space and Caltech recently announced that they have received a patent related to modular, passively-cooled, computing and data storage units which can be assembled into a large-scale…
Key Takeaway: The Space Force’s decision to triple the size of its Lane 1 launch procurement contract underscores its expectation of rapidly increasing demand for commercial space launch services and…
ENCANTA PHARMACEUTICALS, INC. v. PFIZER INC. Before Lourie, Bryson, and Chen. Appeal from the United States District Court for the District of Massachusetts. Summary: A patentee could not argue that…
INTELLECTUAL PIXELS LIMITED v. SONY INTERACTIVE ENTERTAINMENT LLC Before Dyk, Stoll, and Stark. Appeal from the Patent Trial and Appeal Board. Summary: The Board did not exceed the Federal Circuit’s…
Key Takeaways: With demand for high-efficiency power devices continuing to grow, companies are placing greater emphasis on maintaining their competitive advantage by protecting their intellectual property. Companies commercializing gallium nitride…
Following their discussion on the Supreme Court’s consequential decision in Hikma v. Amarin, Knobbe Martens partners Jeremiah Helm and Carol Pitzel Cruz continue their exploration of the biggest patent cases…
In this episode of IP+ with Knobbe Martens, Jeremiah Helm, Co-Chair of Knobbe Martens’ Appellate Litigation practice, and Carol Pitzel Cruz, Co-Chair of the firm’s Hatch-Waxman Litigation practice, discuss one…
Key Takeaways: Descriptive additions to composite trademarks, especially those disclaimed by the applicant, will rarely overcome a Section 2(d) likelihood of confusion where the dominant term is identical. Critically, arguments…
